Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

Grasp protein helps maintain skin health after UVB exposure.

Deleting TNFα gene reduces skin cancer risk in certain mice.

The analysis of a large pilomatricoma revealed five distinct areas with different gene activity related to hair growth and tumor development.

Trps1 plays a key role in hair follicle development and cycling.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Lower SMAD2/3 activation predicts more severe skin cancer.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

The E2 protein affects gene activity in hair follicles of mice.

Ginsenosides Rb₁ and Rd may help prevent hair loss by promoting hair cell growth.

Progerin affects cell shape but not hair or skin in mice.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Mdm2 is crucial for controlling p53 to maintain healthy cells and prevent tumors.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Ptprq has multiple forms that change during inner ear development.

A mouse gene mutation increases the risk of skin cancer.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.